1 |
Todorov L, Kostova I. Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs. Molecules 2023;28. [PMID: 36838947 DOI: 10.3390/molecules28041959] [Reference Citation Analysis]
|
2 |
Silva HVR, da Silva GÁF, Zavan B, Machado RP, de Araujo-neto JH, Ellena JA, Ionta M, Barbosa MIF, Doriguetto AC. The nicotinamide ruthenium(II) complex induces the production of reactive oxygen species (ROS), cell cycle arrest, and apoptosis in melanoma cells. Polyhedron 2023;231:116267. [DOI: 10.1016/j.poly.2022.116267] [Reference Citation Analysis]
|
3 |
Wang Y, Li Y, Chen J, Liu H, Zhou Y, Huang C, Liang L, Liu Y, Wang X. Anticancer effect evaluation of iridium(III) complexes targeting mitochondria and endoplasmic reticulum. J Inorg Biochem 2023;238:112054. [PMID: 36335745 DOI: 10.1016/j.jinorgbio.2022.112054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Dömötör O, Teixeira RG, Spengler G, Avecilla F, Marques F, Lenis-Rojas OA, Matos CP, de Almeida RFM, Enyedy ÉA, Tomaz AI. Ruthenium(II) polypyridyl complexes with benzothiophene and benzimidazole derivatives: Synthesis, antitumor activity, solution studies and biospeciation. J Inorg Biochem 2023;238:112058. [PMID: 36375357 DOI: 10.1016/j.jinorgbio.2022.112058] [Reference Citation Analysis]
|